Screener
BMED vs IHE
iShares Health Innovation Active ETF vs iShares U.S. Pharmaceuticals ETF
Key differences
- IHE costs 0.17% less per year.
- IHE is significantly larger than BMED — larger funds tend to be more liquid and less likely to close.
- BMED follows a active selection strategy; IHE uses index tracking.
- Over the last 3 years, IHE has delivered higher annualized returns.
- IHE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BMED | IHE | |
|---|---|---|
| Annual cost (TER) | 0.55% | 0.38% |
| Fund size (AUM) | $10M | $946M |
| Since | 2020 | 2006 |
| Dividend yield | 0.00% | 1.70% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | active selection | index tracking |
| CAGR 1Y | +18.0% | +46.2% |
| CAGR 3Y | +4.9% | +18.0% |
| CAGR 5Y | +0.1% | +10.1% |
| Sharpe 3Y | 0.16 | 0.87 |
| Volatility 1Y | 14.94% | 16.91% |
| Max drawdown | -36.44% | -29.59% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BMED and IHE
Explore further